<SEC-DOCUMENT>0001209191-21-050467-index.html : 20210809
<SEC-HEADER>0001209191-21-050467.hdr.sgml : 20210809
<ACCEPTANCE-DATETIME>20210809181102
ACCESSION NUMBER:		0001209191-21-050467
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20210809
FILED AS OF DATE:		20210809
DATE AS OF CHANGE:		20210809

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Lavelle Erin
		CENTRAL INDEX KEY:			0001737613

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40708
		FILM NUMBER:		211157738

	MAIL ADDRESS:	
		STREET 1:		C/O ALDER BIOPHARMACEUTICALS, INC.
		STREET 2:		11804 NORTH CREEK PARKWAY SOUTH
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98011

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Eliem Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001768446
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				832273741
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		23515 NE NOVELTY HILL RD., SUITE B221 #1
		CITY:			REDMOND
		STATE:			WA
		ZIP:			98077
		BUSINESS PHONE:		16502240857

	MAIL ADDRESS:	
		STREET 1:		23515 NE NOVELTY HILL RD., SUITE B221 #1
		CITY:			REDMOND
		STATE:			WA
		ZIP:			98077
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc3.xml
<DESCRIPTION>FORM 3 SUBMISSION
<TEXT>
Document 1 - file: doc3.html

Document 1 - RAW XML: doc3.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>attachment1.htm
<DESCRIPTION>EX-24 DOCUMENT
<TEXT>
Document 2 - file: attachment1.htm

</DOCUMENT>
</SEC-DOCUMENT>